Jens Aarøe Selected Research

salicylhydroxamic acid (SHAM)

10/2019

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jens Aarøe Research Topics

Disease

15	Thrombosis (Thrombus) 01/2017 - 10/2006
14	Myocardial Infarction 10/2019 - 10/2006
12	ST Elevation Myocardial Infarction 08/2022 - 08/2013
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 10/2006
10	Death (Near-Death Experience) 01/2019 - 10/2006
5	Infarction (Infarctions) 04/2017 - 08/2015
4	Heart Failure 01/2022 - 05/2016
4	Reperfusion Injury 01/2022 - 02/2014
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 03/2010
2	Aortic Valve Stenosis (Aortic Stenosis) 06/2022 - 10/2018
2	Diabetes Mellitus 01/2019 - 11/2011
2	Stroke (Strokes) 01/2018 - 05/2016
2	Unstable Angina 06/2014 - 01/2014
2	Angina Pectoris 08/2012 - 01/2011
1	Pathologic Constriction (Stenosis) 01/2020
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2017
1	Heart Arrest (Cardiac Arrest) 10/2017
1	Acute Coronary Syndrome 01/2017
1	Hypotension (Low Blood Pressure) 06/2016
1	Chest Pain (Chest Pains) 06/2016
1	Hemorrhage 05/2016
1	Myocardial Reperfusion Injury 01/2016
1	Coronary Occlusion 01/2016
1	Non-ST Elevated Myocardial Infarction 01/2014
1	Stable Angina 01/2014
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2011
1	AIDS-Related Complex (ARC) 08/2008

Drug/Important Bio-Agent (IBA)

8	Sirolimus (Rapamycin)FDA Link 01/2019 - 01/2008
4	omega-Chloroacetophenone (Mace)IBA 01/2020 - 08/2012
4	MelatoninIBA 12/2017 - 02/2014
4	zotarolimusIBA 01/2017 - 03/2010
2	PolymersIBA 01/2017 - 02/2013
1	salicylhydroxamic acid (SHAM)IBA 10/2019
1	BESIBA 01/2019
1	Nitroglycerin (Dynamite)FDA LinkGeneric 06/2016
1	Biomarkers (Surrogate Marker)IBA 07/2014
1	Hormones (Hormone)IBA 02/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2014
1	AntioxidantsIBA 02/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 01/2014
1	ORALIT (ORS)IBA 01/2014
1	Clopidogrel (Plavix)FDA Link 01/2014
1	Everolimus FDA Link 03/2012
1	Lipoproteins (Lipoprotein)IBA 01/2011
1	LipidsIBA 01/2011
1	oxidized low density lipoproteinIBA 01/2011
1	LDL CholesterolIBA 01/2011
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2008

Therapy/Procedure

20	Stents 01/2020 - 10/2006
13	Percutaneous Coronary Intervention 08/2022 - 08/2008
3	Transcatheter Aortic Valve Replacement 06/2022 - 01/2018
2	Ischemic Postconditioning 01/2022 - 01/2017
2	Thrombectomy 01/2022 - 01/2020
2	Drug-Eluting Stents 01/2017 - 02/2013
2	Therapeutics 08/2013 - 08/2008
1	Cardiopulmonary Resuscitation (CPR) 10/2017